Medical Gas and Equipment Market Analysis

The medical gas and equipment sector in the Asia-Pacific has shown quick growth, largely fueled by improvements in healthcare systems, an increase in health-related issues, and ongoing advancements in developing nations like China, India, and Japan. Following the COVID-19 pandemic, the region’s healthcare environments experienced significant changes, revealing serious deficiencies in the supply of oxygen and distribution of medical gases. In reaction, nations made substantial investments in mobile oxygen units, centralized pipeline systems, and onsite oxygen production facilities, addressing both hospital shortages and the inequalities in rural healthcare. For example, China hastened the installation of oxygen generator systems in secondary medical centers, while India launched the PM-CARES Oxygen Mission to ensure a steady supply of medical gas across its territories. From a technical perspective, medical gas and equipment refer to a wide range of systems that facilitate the manufacturing, storage, regulation, and distribution of gases including oxygen, nitrous oxide, nitrogen, and medical air. These are crucial for respiratory treatment, anesthesia, and critical care support. These technologies play an essential role in sustaining oxygen levels in intensive care units, supporting surgical operations, and providing home care for individuals with chronic respiratory conditions. Their presence is not limited to hospitals, as portable concentrators and gas cylinders are increasingly utilized in home therapy and emergency services, enhancing treatment accessibility in both urban and rural areas. The market's expansion is bolstered by domestic production efforts, healthcare reforms by the government, and supportive certification standards like Japan’s PMDA and India’s BIS regulations, which promote local innovation and cost-effectiveness.

Ongoing research and development investments from regional companies are propelling improvements in gas purity assessment, safety measures, and efficiency. Taken together, these advancements establish the Asia-Pacific area as a vibrant and rapidly growing center for medical gas and equipment innovation, narrowing the divide between accessibility, cost, and sophisticated healthcare provision. According to the research report, " Asia - Pacific Medical Gas and Equipment Market Research Report, 2030," published by Actual Market Research, the Asia - Pacific Medical Gas and Equipment market is anticipated to grow at 8.86% CAGR from 2025 to 2030. Substantial government-supported healthcare investments, swift urban development, and the rising prevalence of chronic respiratory and surgical case management. Nations such as China, India, Japan, and South Korea are at the forefront of this evolution, implementing robust national strategies for enhancing healthcare infrastructure and increasing oxygen supply following experiences with the COVID-19 pandemic. Recent changes in the Asia-Pacific region feature substantial governmental budget allocations for medical gas distribution systems, hospital upgrades, and local production of oxygen cylinders and concentrators. For example, India's Make in India program has bolstered domestic production capabilities for medical gas equipment, while China is committed to improving hospital pipeline safety regulations under guidance from the National Health Commission. Likewise, Japan and Australia are progressing in advanced monitoring technologies and optimized gas management systems to boost effectiveness and regulatory compliance. Prominent players in the market include Taiyo Nippon Sanso Corporation, Gulf Cryo, INOX Air Products, along with local branches of Linde Plc and Air Liquide. These firms are heavily investing in on-site oxygen production systems, IoT-driven surveillance, and energy-conscious compressor innovations specifically designed for regional healthcare needs. New opportunities emerge in healthcare digitalization, home-based oxygen therapy, and the rise of medical tourism, all of which are transforming the market dynamics.

The increase in elderly populations in Japan and South Korea, coupled with the growing trend of medical travel in Thailand, Malaysia, and India, is generating steady demand for dependable and affordable medical gas solutions. With enhanced healthcare awareness, improved hospital connectivity, and innovation-focused collaborations, the Asia-Pacific area is set to become a central hub for medical gas equipment production and utilization by the decade’s end..

Market Dynamic

Medical Gas and EquipmentSegmentation

Medical gases lead the Asia-Pacific market because they are essential for respiratory treatments, anesthesia, and emergency medical care, coupled with increased needs from growing healthcare facilities and at-home care services.

In the medical gas and equipment sector in the Asia-Pacific region, medical gases represent the most significant product category, primarily influenced by their crucial importance in treating patients and the swift growth of the healthcare landscape in the area. The consumption of gases like oxygen, nitrous oxide, nitrogen, carbon dioxide, and medical air has escalated in hospitals, clinics, and emergency medical services, as a response to increasing cases of chronic respiratory illnesses, heart diseases, and issues following surgery. Oxygen therapy stands out as a vital treatment for countless patients in countries like India, China, and Japan, where challenges such as pollution, smoking habits, and an aging populace contribute to a high prevalence of respiratory ailments. In the aftermath of the COVID-19 pandemic, leaders across the Asia-Pacific region prioritized the establishment of medical oxygen systems, channeling substantial funds into generation facilities, refilling locations, and distribution pipelines. Initiatives such as India's PM-CARES for oxygen production, hospital growth strategies in China, and Japan's sophisticated ICU infrastructure have together boosted the use of high-quality medical gases. These financial injections not only ensured stable supply chains but also sped up the integration of oxygen concentrators and portable devices in home health care, expanding their application beyond traditional medical settings. Ongoing advancements in the fields of gas production, storage, and monitoring, spearheaded by major industry players like Taiyo Nippon Sanso, INOX Air Products, Gulf Cryo, and Air Liquide, have improved the consistency, purity, and cost-effectiveness of medical gases. Enhanced local manufacturing and encouraging regulatory environments within emerging markets have also increased the availability and affordability of these gases. Consequently, medical gases continue to be the fundamental foundation for therapeutic, surgical, and emergency medical services, ensuring their status as the largest and most vital market segment in the Asia-Pacific medical gas and equipment industry.

The reason the therapeutic sector is the top part of the Asia-Pacific medical gas and equipment market is the rising number of chronic respiratory and heart diseases, alongside the increasing use of oxygen therapy and modern respiratory care tools in hospitals and at home.

The therapeutic application area takes the lead in the Asia-Pacific medical gas and equipment market, mainly because of the increasing incidence of chronic and acute lung problems in the region. Nations such as China, India, Japan, and South Korea are experiencing a rise in conditions like COPD, asthma, sleep apnea, and post-COVID respiratory issues, all of which require regular access to oxygen and other medical gases for effective treatment. Oxygen therapy is crucial it supports life in critical care units, surgical theaters, and emergency rooms, while also helping patients with ongoing respiratory challenges to keep oxygen levels stable at home. In response to this urgent medical need, governments and healthcare providers have taken steps to enhance hospital oxygen systems, build on-site production facilities, and boost the availability of portable concentrators for home care. Initiatives like India’s National Oxygen Plan, the increase of intensive care units in Japan, and the rapid growth of hospitals in urban areas in China have all contributed to the heightened use of medical gases for therapy. Innovations in non-invasive breathing support, high-flow nasal oxygen options, and intelligent respiratory tracking have broadened the applications of gas-based therapy, making it more common in recovery after surgery as well as in managing chronic conditions. At the same time, heightened awareness of healthcare and improved insurance coverage is motivating patients to pursue treatment sooner, leading to a greater demand for therapeutic gases. Major companies are offering affordable and energy-efficient therapeutic gas solutions designed for both hospital and home use. As lung and heart diseases continue to be top contributors to death rates in the Asia-Pacific region, therapeutic uses will remain central to the medical gas and equipment sector, ensuring that they are accessible, affordable, and crucial for life-saving care across various healthcare environments.

Hospitals lead the Asia-Pacific market for medical gases and equipment because of their large infrastructure, significant patient numbers, and essential need for a constant supply of oxygen and anesthesia throughout intensive care, surgical, and emergency departments.

The segment of hospitals represents the largest portion of the Asia-Pacific market for medical gases and equipment, driven by the region's quickly growing healthcare infrastructure, an increase in patient admissions, and a strong dependence on medical gases for daily functions. Hospitals located in China, India, Japan, South Korea, and Australia are the main buyers of oxygen, nitrous oxide, nitrogen, and medical air these gases are crucial for sustaining patient life, administering anesthesia, and providing care after surgery. The considerable number of patients in these nations, alongside the rising count of intensive care units ICUs and operation theatres, has greatly increased the need for extensive gas pipeline systems and centralized oxygen supply setups. In the aftermath of the COVID-19 pandemic, regional governments have focused on ensuring hospital oxygen readiness and expanding pipeline projects. China has set forth new standards for hospital oxygen systems through its National Health Commission, and India's PM-CARES initiative has facilitated the establishment of over 1,500 on-site oxygen production facilities in various hospitals. Likewise, Japan and South Korea have enhanced their critical care systems with automated gas monitoring and advanced technologies for safety compliance. Hospitals are also at the forefront of using integrated gas management and monitoring systems, which guarantee consistent, high-quality gas supply for surgeries and emergency situations. The trend towards multi-specialty and tertiary care hospitals, combined with increased healthcare spending and medical tourism in nations like Thailand and Malaysia, has heightened institutional demand. Major providers are collaborating with hospitals to offer scalable, energy-efficient solutions for pipelines and storage. Hospitals continue to be the foundation of medical gas needs in Asia-Pacific, contributing to the highest levels of consumption due to their intensive clinical operations, large-scale activities, and essential role in providing life-saving treatments across the healthcare sector.

Medical Gas and Equipment Market Regional Insights

China is at the forefront of the Asia-Pacific medical gas and equipment sector because of its extensive healthcare infrastructure, significant governmental investments in oxygen production and hospital upgrades, along with a solid domestic manufacturing base supported by innovation driven by policy.

China holds the position of the largest and most influential market for medical gas and equipment within the Asia-Pacific area, fueled by its vast healthcare framework, supportive policies, and manufacturing abilities. In the last ten years, the Chinese government has heavily invested in expanding hospitals, reforming public health systems, and enhancing oxygen infrastructure as part of its Healthy China 2030 strategy. With over 35,000 hospitals and an increasingly aging population, there has been a significant rise in the need for oxygen, nitrous oxide, nitrogen, and vacuum systems, particularly in intensive care units, surgical departments, and emergency rooms. The COVID-19 pandemic has also intensified the country’s commitment to self-sufficiency in medical oxygen, prompting the setup of thousands of on-site oxygen generation facilities and the creation of national medical gas stockpiles for public hospitals. China enjoys the advantage of a robust domestic manufacturing environment, positioning it as a regional center for the production of medical gas apparatus such as cylinders, regulators, compressors, and concentrators. This industrial synergy allows China to fulfill its own healthcare needs while aiding other Asia-Pacific countries during times of shortage. The nation’s rigorous oversight by the National Medical Products Administration NMPA guarantees that product quality and safety standards are met, enhancing confidence in the market. The integration of smart hospital solutions, like IoT-based gas monitoring systems and automated refilling processes, further improves efficiency and dependability. With strong research and development efforts, policy initiatives, and unmatched manufacturing capabilities, China sustains its leadership in the Asia-Pacific medical gas and equipment sector establishing standards in scalability, innovation, and healthcare access.